- PhD, Communication, University of Maryland, College Park
- MA, Mass Communication, University of Minnesota
- BA, Strategic Communications, University of Minnesota
Vanessa Boudewyns conducts interdisciplinary research on message design and behavior prediction and change. A member of our Science in the Public Sphere Research Program, she uses theories of behavior change, persuasion and social influence, and communication to understand, develop, and evaluate mass media campaigns, advertising, and other messages. She is skilled in experimental design, survey development, and quantitative data collection and analysis.
In her time at RTI, Dr. Boudewyns has contributed to research on sexually transmitted infections, HIV/AIDS, prescription drug promotion to both consumers and providers, and cancer screening decision-making. She currently leads an effort for the U.S. Food and Drug Administration to test consumers’ and health care practitioners’ interpretations of marketing claims in prescription drug websites. Also for the FDA, she leads a test of health care practitioners’ understanding of preliminary clinical data encountered through medical product promotional materials. For the Centers for Disease Control and Prevention, she is the lead evaluator for two ongoing Act Against AIDS campaigns—“Start Talking. Stop HIV.” and “Doing It.”
Dr. Boudewyns joined RTI in 2012. Previously, she was a consultant for the Academy for Educational Development. She is a member of the American Council on Consumer Interests, American Association for Public Opinion Research, Association for Psychological Science, the International Communication Association, the Society for Medical Decision Making, and serves as a guest reviewer for the journals Health Communication, Communication Quarterly, and International Journal of Pharmaceutical and Healthcare Marketing.